Nortec Pharma Sells Majority Stake to Frewitt

Deal News | Mar 19, 2025 | CEE Legal Matters

Schoenherr has facilitated the sale of a majority stake in Nortec Pharma by its shareholders to Frewitt, expanding the latter's product range and service offering in the pharmaceutical industry. Nortec Pharma, based in Poland, is known for its pharmaceutical processing solutions, while Frewitt is a Swiss-based firm in milling and processing technologies. The transaction represents a strategic move for both companies, enhancing their innovative capabilities and market reach. The Schoenherr legal team included Partners Tomasz Kwasniewski and Szymon Okon, Counsel Dawid Brudzisz, and Associate Witold Oszczanowski. Financial terms of the deal remain undisclosed.

Sectors

Pharmaceuticals
Manufacturing and Processing Technology

Geography

Poland – Nortec Pharma is headquartered in Poland.
Switzerland – Frewitt is based in Switzerland.

Industry

Pharmaceuticals – The article involves companies providing pharmaceutical processing solutions.
Manufacturing and Processing Technology – Frewitt is involved in milling and processing technologies which align with this sector.

Financials

Undisclosed – The financial details of the majority stake sale have not been disclosed.

Participants

Name	Role	Type	Description
Nortec Pharma	Target Company	Company	A Polish firm specializing in pharmaceutical processing solutions.
Frewitt	Bidding Company	Company	A Swiss-based company focusing on milling and processing technologies for the pharmaceutical industry.
Schoenherr	Legal Advisor	Company	A law firm involved in advising the shareholders of Nortec Pharma on the transaction.
Tomasz Kwasniewski	Partner	Person	Partner at Schoenherr who worked on the transaction.
Szymon Okon	Partner	Person	Partner at Schoenherr who worked on the transaction.
Dawid Brudzisz	Counsel	Person	Counsel at Schoenherr involved in the transaction.
Witold Oszczanowski	Associate	Person	Associate at Schoenherr involved in the transaction.